<DOC>
	<DOCNO>NCT02867163</DOCNO>
	<brief_summary>This observational trial estimate incidence deep vein thrombosis ( DVT ) total knee replacement patient receive intraoperative dose tranexamic acid .</brief_summary>
	<brief_title>Tranexamic Acid Blood Clots Knee Surgery</brief_title>
	<detailed_description>This study anticipate consist 30 participant 18 year age schedule total knee arthroplasty Sandoval Regional Medical Center administer intraoperative tranexamic acid , meet exclusion criterion . The patient examine postoperative day 1 . Lower-extremity ultrasound use screen deep vein thrombosis ( DVT ) . Incidence data DVT compare historical incidence rate institution total knee arthroplasty without use tranexamic acid , approximately 12 % . Patients find screen deep vein thrombosis refer appropriate care .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Adult patient schedule total knee arthroplasty Sandoval Regional Medical Center intraoperative dose tranexamic acid Previous deep vein thrombosis pulmonary embolism episode Known coronary artery disease peripheral vascular disease Previously diagnose hypercoagulable state ( e.g . Leiden factor V , antiphospholipid antibody , protein C S deficiency ) Pregnancy Creatinine clearance le 30 ml/min Nonfluency English</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>